Drug Pipeline

KarXT Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
18
Active Studies
15
Recruiting
16
Phase 3
2
Top Sponsors
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-12 NCT07118215
A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine…
date change Primary completion pushed: 2026-04-05 -> 2026-06-25
2026-06-12 NCT07118215
A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine…
date change Completion pushed: 2026-04-05 -> 2026-06-25
2026-06-05 NCT06951711
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes…
Trial sites expanded: 74 -> 78 locations
2026-06-03 NCT05980949
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in…
Trial sites expanded: 421 -> 426 locations
2026-05-23 NCT06937229
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in…
Trial sites expanded: 243 -> 253 locations
Active Studies by Phase
Phase 3
16
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06951698 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes… Bipolar-I Disorder With Mania or Mania With Mixed Features Recruiting
NCT05511363 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated… Psychosis Associated With Alzheimer's Disease Recruiting
NCT07424404 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the… Schizophrenia Recruiting
NCT06882785 A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult… Schizophrenia Recruiting
NCT06976216 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment… Alzheimer's Disease Recruiting
NCT05980949 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in… Psychosis Associated With Alzheimer's Disease Recruiting
NCT06126224 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated… Psychosis Associated With Alzheimer's Disease Recruiting
NCT06929273 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in… Bipolar Disorder Type I With Mania Recruiting
NCT06937229 A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in… Alzheimer Disease Recruiting
NCT06947941 A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis… Alzheimer Disease Recruiting
NCT07288567 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia… Schizophrenia Recruiting
NCT06951711 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes… Bipolar Disorder Type I With Mania or Mania With Mixed Features Recruiting
NCT06976203 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment… Alzheimer's Disease Recruiting
NCT06585787 A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's… Alzheimer Disease Recruiting
NCT07284745 A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With… Irritability Associated With Autism Spectrum Disorder Not Yet Recruiting
NCT07285798 A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With… Irritability Associated With Autism Spectrum Disorder Not Yet Recruiting
Phase 1
NCT07118215 A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine… Healthy Volunteers Recruiting
Not specified
NCT07571148 Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among… Schizophrenia Active, Not Recruiting
Sponsors Running KarXT Trials
Disease Areas
Get alerts when KarXT trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free